by jlohrconsulting | Sep 6, 2025 | Uncategorized
Int J Risk Saf Med. 2025 Sep 5:9246479251377340. doi: 10.1177/09246479251377340. Online ahead of print. ABSTRACT This patient commentary addresses the absence of rigorous placebo- or sham-controlled trials for electroconvulsive therapy (ECT) and discusses whether its...
by jlohrconsulting | Sep 6, 2025 | Uncategorized
J Adv Nurs. 2025 Sep 5. doi: 10.1111/jan.70193. Online ahead of print. ABSTRACT AIM: To synthesise evidence on the impact of pre- and post-loss family support interventions on bereavement outcomes and families’ perceptions of their usefulness and benefits in...
by jlohrconsulting | Sep 6, 2025 | Uncategorized
CNS Neurosci Ther. 2025 Sep;31(9):e70600. doi: 10.1111/cns.70600. ABSTRACT BACKGROUND: Depression is a common mental illness with a high relapse rate, which has a serious negative impact on national economic development and happiness. At present, the pathogenesis of...
by jlohrconsulting | Sep 6, 2025 | Uncategorized
Int J Eat Disord. 2025 Sep 5. doi: 10.1002/eat.24538. Online ahead of print. ABSTRACT OBJECTIVE: Converging evidence from neuroimaging studies and genome-wide association study (GWAS) suggests the involvement of prefrontal cortex (PFC) and striatum dysfunction in the...
by jlohrconsulting | Sep 6, 2025 | Uncategorized
Biol Psychiatry. 2025 Oct 1;98(7):515-516. doi: 10.1016/j.biopsych.2025.07.013. NO ABSTRACT PMID:40912759 | DOI:10.1016/j.biopsych.2025.07.013
Recent Comments